A Propensity-Matched Analysis of Survival of Clinically Diagnosed Early-Stage Lung Cancer and Biopsy-Proven Early-Stage Non-Small Cell Lung Cancer Following Stereotactic Ablative Radiotherapy
PurposeStereotactic body radiotherapy (SBRT) has been increasingly regarded as a reasonable option for early-stage lung cancer patients without pretreatment pathologic results, but the efficacy and safety in a Chinese population remains unclear. The aim of this study was to compare survival outcomes...
Main Authors: | Ran Zhang, Yanling Guo, Yujie Yan, Yuanjun Liu, Yaoyao Zhu, Jingjing Kang, Fangjuan Li, Xiaojiang Sun, Ligang Xing, Yaping Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.720847/full |
Similar Items
-
Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation
by: Hanbo Chen, et al.
Published: (2018-08-01) -
Radiation Pneumonitis After Stereotactic Body Radiation Therapy for Early Stage
Non-small Cell Lung Cancer
by: Lu CHEN, et al.
Published: (2014-04-01) -
Lung stereotactic body radiation therapy for elderly patients aged ≥ 80 years with pathologically proven early-stage non-small cell lung cancer: a retrospective cohort study
by: Kenta Watanabe, et al.
Published: (2021-02-01) -
Results of Treatment with Stereotactic Radiotherapy in Patients with Early-Stage Medically Inoperable Non-Small Cell Lung Cancer
by: Cengiz Gemici
Published: (2017-06-01) -
Approach and assessment of automated stereotactic radiotherapy planning for early stage non-small-cell lung cancer
by: Xue Bai, et al.
Published: (2019-10-01)